ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Numerous studies have shown that reduced adiponectin levels are associated with obesity, insulin resistance, dyslipidemia, hypertension, and an increased risk of type 2 diabetes and cardiovascular disease.